Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.
about
Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer.Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss.Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.Current and future chemical therapies for treating anaemia in chronic kidney disease.Investigational therapies for renal disease-induced anemia.Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts.Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules.Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target
P2860
Q33912255-74FD9DE3-A9ED-45EB-8E34-63B7AD4C2E27Q37144501-003F961B-0901-4A4F-B3B7-1DF600FAF6A5Q37555493-D9246FD3-1594-4971-8518-5C1ABB941F23Q38690858-3DFC2E07-7484-4B43-8F55-DA73E55053AAQ38819455-5D7993DF-8D37-4D55-9969-41A5C730BB11Q38946634-CAFF1C43-0D91-43BC-B392-62C4ED001394Q38988997-8EE05680-EB33-4562-809E-2167A3C8E230Q39134073-DEA168B9-AF0E-4909-A8F2-AC01278311E7Q42371815-03F55E77-F48C-4B96-AEBE-D12D48D6FC9A
P2860
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sotatercept (ACE-011) for the ...... ults from two phase 2 studies.
@ast
Sotatercept (ACE-011) for the ...... ults from two phase 2 studies.
@en
type
label
Sotatercept (ACE-011) for the ...... ults from two phase 2 studies.
@ast
Sotatercept (ACE-011) for the ...... ults from two phase 2 studies.
@en
prefLabel
Sotatercept (ACE-011) for the ...... ults from two phase 2 studies.
@ast
Sotatercept (ACE-011) for the ...... ults from two phase 2 studies.
@en
P2093
P2860
P1476
Sotatercept (ACE-011) for the ...... ults from two phase 2 studies.
@en
P2093
Abderrahmane Laadem
Cynthia Osborne
Haralambos Raftopoulos
Jeffrey Crawford
Jerome Goldschmidt
John A Glaspy
Marie Puccio-Pick
Matthew L Sherman
P2860
P2888
P304
P356
10.1007/S00520-015-2929-9
P577
2015-09-14T00:00:00Z